Treace Medical Concepts (TMCI) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Utah Medical Products (UTMD) has outperformed Treace Medical Concepts (TMCI) over the past year, gaining 16.5% versus a loss of 37.1%. Over five years, UTMD leads with a -17.9% price change compared with -84.1% for TMCI. Treace Medical Concepts is the larger company by market cap ($252.0 million vs $234.5 million), about 1.1 times the size.
Utah Medical Products pays a dividend yielding 1.67%, while Treace Medical Concepts does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TMCI | UTMD |
|---|---|---|
| Share price | $3.88 | $73.88 |
| Market cap | $252.01M | $234.47M |
| 1-day change | -0.39% | +0.58% |
| YTD return | +58.16% | +32.01% |
| 1-year return | -37.09% | +16.47% |
| 5-year return | -84.13% | -17.93% |
| P/E ratio (TTM) | — | 22.52 |
| EPS (TTM) | $-0.92 | $3.28 |
| Dividend yield | 0.00% | 1.67% |
| Annual dividend | $0.00 | $1.24 |
| 52-week high | $7.08 | $76.89 |
| 52-week low | $1.17 | $53.66 |
| Distance from 52-week high | -45.27% | -3.92% |
| Analyst consensus | none | — |
| Avg. price target upside | +41.94% | — |
| Average volume | 330.27K | 34.56K |
| Shares outstanding | 65.03M | 3.17M |
| Employees | 450 | 140 |
| Sector | Health Care | Healthcare |
| Industry | Medical/Dental Instruments | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UTMD has outperformed TMCI by 53.6 percentage points over the past year.
- Utah Medical Products offers a meaningfully higher dividend yield (1.67% vs 0.00%).
- The two companies sit in different sectors: Treace Medical Concepts in Health Care and Utah Medical Products in Healthcare.
About Treace Medical Concepts
TMCI stock →Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions.
Health Care · Medical/Dental Instruments · 450 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Healthcare · Medical Instruments & Supplies · 140 employees
TMCI vs UTMD FAQ
Which is bigger, Treace Medical Concepts or Utah Medical Products?
Treace Medical Concepts (TMCI) is larger, with a market capitalization of $252.01M compared with $234.47M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, TMCI or UTMD?
UTMD returned +16.47% over the past 12 months, compared with -37.09% for TMCI (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Treace Medical Concepts or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.67%, while Treace Medical Concepts does not currently pay a regular dividend.
Are Treace Medical Concepts and Utah Medical Products in the same industry?
No. Treace Medical Concepts is in the Health Care sector, while Utah Medical Products is in Healthcare.